Abstract
Alpha-1-antitrypsin (α1AT) is a protease inhibitor, the deficiency of which is associated with premature emphysema and a wide spectrum of liver disease. This protein is a small glycoprotein that migrates electrophoretically with the α1-globulin fraction of serum. Alpha-1-antitrypsin is a protein coded for by a gene, referred to as PI, located on the long arm of chromosome 14. That certain forms of premature emphysema had an inherited basis was first postulated by Laurell, Eriksson, and Axelsson in 1965 (1). Electrophoretic variants of α1AT were described throughout the 1960s. The first description of infantile liver cirrhosis in a homozygote for α1AT deficiency was made by Gans et al. in 1969 (2). Neonatal cholestasis associated with alpha-1-antitrypsin deficiency was described in 1972 (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eriksson S. Studies in alpha-1-antitrypsin deficiency. Acta Med Scand Suppl 1965;432:1–85.
Gans H, Sharp HL, Tan BH. Antiprotease deficiency and familial infantile liver cirrhosis. Surg Gynec Obstet 1969;129:289–299.
Aagenaes O, Matlary A, Elgjo K, Munthe E, Fagerhol M. Neonatal cholestasis in alpha-1-antitrypsin deficient children: clinical, genetic, histological and immunohistochemical findings. Acta Paediat Scand 1992;61:632–642.
Stevens PM, Hnilica V, Johnson PC, Bell RL. Pathophysiology of hereditary emphysema. Ann Intern Med 1971;74:672–680.
Kennedy M, Brett W. Monozygotic twins with alpha-1-antitrypsin deficiency (Letter). Lancet 1985;1(8427):527–528.
Nukiwa T, Satoh K, Brantly M L, et al. Identification of a second mutation in the protein-coding sequence of the Z type alpha-1-antitrypsin gene. J Biol Chem 1986;261:15, 989-15,994.
Cox DW, Woo SLC, Mansfield T. DNA restriction fragments associated with alpha-1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature 1985;316:79–88.
Roychoudhury AK, Nei M. Human polymorphic genes: world distribution. Oxford Univ Press, New York, 1988, pp. 132–135.
Cox DW. Alpha-1-antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. McGraw-Hill, New York, 1989, pp. 2409–2437.
Crystal RG. The alpha-1-antitrypsin gene and its deficiency states. Trends Genet 1989;5:411–417.
Cox DW, Smyth S. Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med 1983;74:221–227.
Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant alpha-1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha-1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014–9018.
DeCroo, S, Kamboh MI, Ferrell RE. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks. Hum Hered 1991;41:215–221.
Nukiwa T, Brantly ML, Ogushi F, Fells GA, Crystal RG. Characterization of the gene and protein of the common alpha-1-antitrypsin normal M2 allele. Am J Hum Genet 1988;43:322–330.
Kidd VJ, Wallace RB, Itakura K, Woo SLC. Alpha-1-antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature 1983;304:230–234.
Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha-1-antitrypsin accumulation in the liver. Nature 1992;357:605–607.
Sifers RN, Rogers BB, Hawkins HK, Finegold MJ, Woo SLC. Elevated synthesis of human alpha 1-antitrypsin hinders secretion of murine alpha-1-antitrypsin from hepatocytes of transgenic mice. J Biol Chem 1989;264:15,696-15,700.
Loebermann H, Tokuoka R, Deisenhofer J, Huber R. Human a 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 1984;177:531–536.
Sveger T. Liver disease in alpha-1-antitrypsin deficiency detected by screening in 200,000 infants. N Engl J Med 1976;294:1316–1321.
Sveger T. Prospective study of children with alpha-1-antitrypsin deficiency: eight year old follow-up. J Pediatr 1989;104:91–94.
Moroz SP, Cutz E, Cox DW, Sass-Kortsak A. Liver disease associated with alpha-1-antitrypsin deficiency in childhood. J Pediatr 1976;88:19–25.
Clark P, Breit SN, Dawkins RL, Penny R. Genetic study of a family with two members with Weber-Christian disease (panniculitis) and alpha-1-antitrypsin deficiency. Am J Med Genet 1982; 13:57–62.
Fortin PR, Fraser RS, Watts CS, Esdaile JM. Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis. J Rheum 1991;18:1613–1616.
Lewis JH, Iammarino RM, Spero JA, Hasiba U. Pittsburgh: an alpha-1-antitrypsin variant causing hemorrhagic disease. Blood 1978;51:129–137.
Owen MC, Brennan SO, Lewis JH, Carrell RW. Mutation of antitrypsin to antithrombin: alpha-1-antitrypsin Pittsburgh (358 met-to-arg), a fatal bleeding disorder. New Engl J Med 1983;309:694–698.
Moroz SP, et al. Membranoproliferative glomerulonephritis in childhood cirrhosis associated with alpha-1-antitrypsin deficiency. Pediatrics 1976;88:19–25.
Wewers MD, Casolaro A, Sellers S, et al. Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055–1062.
Pittschieler K. Heterozygotes and liver involvement. Acta Paediatr 1994;393:21S–23S.
Perlmutter DH. Clinical manifestations of alpha-1-antitrypsin deficiency. Gastroenterology Clin N Am 1995;24:27–43.
Garver RI Jr, Chytil A, Courtney M, Crystal RG. Clonal gene therapy: transplanted mouse fibroblast clones express human alpha-1-antitrypsin gene in vivo. Science 1987;237:762–764.
Kay MA, Baley P, Rothenberg S, et al. Expression of human alpha-1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 1992;89:89–93.
Lemarchand P, Jaffe HA, Danel C, et al. Adenovirus-mediated transfer of a recombinant human alpha-1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci USA 1992;89:6482–6486.
Brantly M, Courtney M, Crystal RG. Repair of the secretion defect in the Z form of alpha-1-antitrypsin by addition of a second mutation. Science 1988;242:1700–1702.
Ozaki I, Duan L, Liu SL, Pomerantz RJ, Zern MA. Application of ribozymes for gene therapy of liver disease in a 1-antitrypsin deficiency. Molecular diagnosis and gene therapy. Kluwar Academic Publishers, Dordrecht, Netherlands, 1996, pp. 106–115.
Ibarguen E, Gross CR, Savik SK, Sharp HL. Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr 1990; 117:864–870.
Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1986;314:736–739.
Campra JL, Craig JP, Peters RL, Reynolds TB. Cirrhosis associated with partial deficiency of alpha-1-antitrypsin in adults. Ann Intern Med 1973;78:233–238.
Sveger T. Screening for alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:18S–20S.
Udall JN Jr, Dixon M, Newman AP, Wright JA, James B, Bloch KJ. Liver disease in alpha 1-antitrypsin deficiency. A retrospective analysis of the influence of early breast-vs bottle-feeding. JAMA 1985;253:2679–2682.
Psacharopoulos HT, Mowat AP, Cook PJ, Carlile PA, Portmann B, Rodeck CH. Outcome of liver disease associated with alpha-1-antitrypsin deficiency (PiZ). Implications for genetic counseling and antenatal diagnosis. Arch Dis Child 1983;58:882–887.
Esquivel CO, Marino IR, Fioravanti V, Van Thiel DH. Liver transplantation for metabolic disease of the liver. Gastroenterol Clin North Am 1988; 17:167–175.
Burdelski M. Diagnostic, preventive, medical and surgical management of alpha-1-antitrypsin deficiency in childhood. Acta Paediatr 1994;393:33S–36S.
Suggested Reading
Alagille D. Alpha-1-Antitrypsin deficiency. Hepatology 1984;4:11S–14S.
Deutsch J, Becker H, Aubock L. Histopathological features of liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:8S–12S.
Eriksson SG. Liver disease in alpha 1-antitrypsin deficiency. Aspects of incidence and prognosis. Scand J Gastroenterol 1985;20:907–911.
Massi G, Chiarelli C. Alpha-1-antitrypsin: molecular system and the Pi system. Acta Paediatr 1994;393:1S–4S.
Poley JR. Malignant liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393:27S–32S.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herrine, S.K., Zern, M.A. (1998). Alpha-1-Antitrypsin Deficiency. In: Wu, G.Y., Israel, J. (eds) Diseases of the Liver and Bile Ducts. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1808-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1808-1_20
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7293-9
Online ISBN: 978-1-4612-1808-1
eBook Packages: Springer Book Archive